A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer.

Khalid Matin; Samuel A Jacobs; Thomas Richards; Michael K Wong; Martin Earle; Terry Evans; Monica Troetschel; William Ferri; David Friedland; Richard Pinkerton

doi:10.1097/01.coc.0000170797.36351.3a

A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer.

Identifier:nobleid.org/w1/20260515/E55FF2B2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/E55FF2B2.svg?ark=w1%2F20260515%2FE55FF2B2)](https://nobleid.org/work/w1/20260515/E55FF2B2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer.

Identifier:nobleid.org/w1/20260515/E55FF2B2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/E55FF2B2.svg?ark=w1%2F20260515%2FE55FF2B2)](https://nobleid.org/work/w1/20260515/E55FF2B2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work